Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 Per Share
-
Shares outstanding
-
14,033,333
-
Total 13F shares
-
12,143,231
-
Share change
-
-131,058
-
Total reported value
-
$401,082,257
-
Put/Call ratio
-
72%
-
Price per share
-
$33.03
-
Number of holders
-
136
-
Value change
-
-$15,149,040
-
Number of buys
-
69
-
Number of sells
-
77
Institutional Holders of Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) as of Q2 2015
As of 30 Jun 2015,
Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,143,231 shares.
The largest 10 holders included
THOMPSON SIEGEL & WALMSLEY LLC, BlackRock Fund Advisors, WELLINGTON MANAGEMENT GROUP LLP, LOMBARDIA CAPITAL PARTNERS LLC, DIMENSIONAL FUND ADVISORS LP, BTIM Corp., VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., Portolan Capital Management, LLC, and AMI ASSET MANAGEMENT CORP.
This page lists
136
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.